Somatic gain-of-function mutation of KIT has been documented in several human malignancies, notably acute myelogenous leukaemia, systemic mast cell disease, germ cell tumours and gastrointestinal stromal tumours (GIST) (Heinrich et al, 2002). This evidence concerns the gene KIT and gastrointestinal stromal tumor.